Quantcast
Channel: businesspress24.com
Viewing all articles
Browse latest Browse all 68521

IsoRay''s Cesium-131 Selected by Chicago Prostate Cancer Center for Use in the Launch of a Study of the Focal Treatment of Prostate Cancer

$
0
0
RICHLAND, WA -- (Marketwired) -- 06/29/15 -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in brachytherapy and medical isotope applications, today announced that Dr. Brian J. Moran, Director of Chicago Prostate Cancer Center in Westmont, Illinois, has initiated a study o ...

Viewing all articles
Browse latest Browse all 68521

Trending Articles